212 related articles for article (PubMed ID: 12487926)
21. VEGF-mediated angiogenesis of human pheochromocytomas is associated to malignancy and inhibited by anti-VEGF antibodies in experimental tumors.
Zielke A; Middeke M; Hoffmann S; Colombo-Benkmann M; Barth P; Hassan I; Wunderlich A; Hofbauer LC; Duh QY
Surgery; 2002 Dec; 132(6):1056-63; discussion 1063. PubMed ID: 12490855
[TBL] [Abstract][Full Text] [Related]
22. Anti-VEGF antibody in experimental hepatoblastoma: suppression of tumor growth and altered angiogenesis.
McCrudden KW; Hopkins B; Frischer J; Novikov A; Huang J; Kadenhe A; New T; Yokoi A; Yamashiro DJ; Kandel JJ; Middlesworth W
J Pediatr Surg; 2003 Mar; 38(3):308-14; discussion 308-14. PubMed ID: 12632340
[TBL] [Abstract][Full Text] [Related]
23. [Vascular endothelial growth factor gene expression in nasopharyngeal carcinoma cell line induced by hypoxia in vitro].
Yang HF; Tang WP
Ai Zheng; 2003 Feb; 22(2):160-3. PubMed ID: 12600291
[TBL] [Abstract][Full Text] [Related]
24. Vascular endothelial growth factor secretion by tumor-infiltrating macrophages essentially supports tumor angiogenesis, and IgG immune complexes potentiate the process.
Barbera-Guillem E; Nyhus JK; Wolford CC; Friece CR; Sampsel JW
Cancer Res; 2002 Dec; 62(23):7042-9. PubMed ID: 12460925
[TBL] [Abstract][Full Text] [Related]
25. beta-Catenin regulates vascular endothelial growth factor expression in colon cancer.
Easwaran V; Lee SH; Inge L; Guo L; Goldbeck C; Garrett E; Wiesmann M; Garcia PD; Fuller JH; Chan V; Randazzo F; Gundel R; Warren RS; Escobedo J; Aukerman SL; Taylor RN; Fantl WJ
Cancer Res; 2003 Jun; 63(12):3145-53. PubMed ID: 12810642
[TBL] [Abstract][Full Text] [Related]
26. Expression of endocrine gland-derived vascular endothelial growth factor in ovarian carcinoma.
Zhang L; Yang N; Conejo-Garcia JR; Katsaros D; Mohamed-Hadley A; Fracchioli S; Schlienger K; Toll A; Levine B; Rubin SC; Coukos G
Clin Cancer Res; 2003 Jan; 9(1):264-72. PubMed ID: 12538479
[TBL] [Abstract][Full Text] [Related]
27. Antiangiogenic gene therapy for hepatocellular carcinoma using angiostatin gene.
Ishikawa H; Nakao K; Matsumoto K; Ichikawa T; Hamasaki K; Nakata K; Eguchi K
Hepatology; 2003 Mar; 37(3):696-704. PubMed ID: 12601367
[TBL] [Abstract][Full Text] [Related]
28. [Expression of VEGF and inhibition of tumor angiogenesis by abrogation of VEGF in head and neck cancer].
Riedel F
Laryngorhinootologie; 2003 Jun; 82(6):436-7. PubMed ID: 12851852
[No Abstract] [Full Text] [Related]
29. [Effects of anti-HPV16 E6-ribozyme on invasiveness of cervical carcinoma cell line CaSKi and vascular endothelial growth factor expression].
Liu K; Wang LL; Zheng YF; Zhang JR
Di Yi Jun Yi Da Xue Xue Bao; 2004 May; 24(5):529-32. PubMed ID: 15151824
[TBL] [Abstract][Full Text] [Related]
30. [Enhancement by hypoxia of antisense VEGF(165) gene expression in esophageal cancer cells].
Guo WZ; Ran YL; Liu J; Yu L; Sun LX; Yang ZH
Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2002 Sep; 34(5):625-9. PubMed ID: 12198567
[TBL] [Abstract][Full Text] [Related]
31. Interleukin-6 promotes cervical tumor growth by VEGF-dependent angiogenesis via a STAT3 pathway.
Wei LH; Kuo ML; Chen CA; Chou CH; Lai KB; Lee CN; Hsieh CY
Oncogene; 2003 Mar; 22(10):1517-27. PubMed ID: 12629515
[TBL] [Abstract][Full Text] [Related]
32. Decreased Src tyrosine kinase activity inhibits malignant human ovarian cancer tumor growth in a nude mouse model.
Wiener JR; Nakano K; Kruzelock RP; Bucana CD; Bast RC; Gallick GE
Clin Cancer Res; 1999 Aug; 5(8):2164-70. PubMed ID: 10473101
[TBL] [Abstract][Full Text] [Related]
33. VEGF-targeted short hairpin RNA inhibits intraperitoneal ovarian cancer growth in nude mice.
Bai Y; Deng H; Yang Y; Zhao X; Wei Y; Xie G; Li Z; Chen X; Chen L; Wang Y; Su D; Qian Z; Zhong Q; Luo H; Yi T
Oncology; 2009; 77(6):385-94. PubMed ID: 20130421
[TBL] [Abstract][Full Text] [Related]
34. Vascular endothelial growth factor C stimulates progression of human gastric cancer via both autocrine and paracrine mechanisms.
Kodama M; Kitadai Y; Tanaka M; Kuwai T; Tanaka S; Oue N; Yasui W; Chayama K
Clin Cancer Res; 2008 Nov; 14(22):7205-14. PubMed ID: 19010837
[TBL] [Abstract][Full Text] [Related]
35. Expression of vascular endothelial growth factor is necessary but not sufficient for production and growth of brain metastasis.
Yano S; Shinohara H; Herbst RS; Kuniyasu H; Bucana CD; Ellis LM; Davis DW; McConkey DJ; Fidler IJ
Cancer Res; 2000 Sep; 60(17):4959-67. PubMed ID: 10987313
[TBL] [Abstract][Full Text] [Related]
36. Albendazole: a potent inhibitor of vascular endothelial growth factor and malignant ascites formation in OVCAR-3 tumor-bearing nude mice.
Pourgholami MH; Yan Cai Z; Lu Y; Wang L; Morris DL
Clin Cancer Res; 2006 Mar; 12(6):1928-35. PubMed ID: 16551879
[TBL] [Abstract][Full Text] [Related]
37. Thalidomide down-regulates the expression of VEGF and bFGF in cisplatin-resistant human lung carcinoma cells.
Li X; Liu X; Wang J; Wang Z; Jiang W; Reed E; Zhang Y; Liu Y; Li QQ
Anticancer Res; 2003; 23(3B):2481-7. PubMed ID: 12894531
[TBL] [Abstract][Full Text] [Related]
38. [Correlation of expression of vascular endothelial growth factor and matrix matalloproteinase-2 to invasion of ovarian tumor cells in vitro].
Zhang AL; Wang SX; Lu YP; Li J; Wang CY; Ma D
Ai Zheng; 2002 Mar; 21(3):263-6. PubMed ID: 12451991
[TBL] [Abstract][Full Text] [Related]
39. Matrix metalloproteinases (MMP9 and MMP2) induce the release of vascular endothelial growth factor (VEGF) by ovarian carcinoma cells: implications for ascites formation.
Belotti D; Paganoni P; Manenti L; Garofalo A; Marchini S; Taraboletti G; Giavazzi R
Cancer Res; 2003 Sep; 63(17):5224-9. PubMed ID: 14500349
[TBL] [Abstract][Full Text] [Related]
40. [Experimental research of gene therapy for human gliomas with vascular endothelial growth factor(165) antisense RNA].
Zhang X; Wu J; Gao D
Zhonghua Yi Xue Za Zhi; 2000 May; 80(5):386-8. PubMed ID: 11798792
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]